Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31749 | 119 | 35.5 | 93% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3119 | 1786 | CANAVAN DISEASE//PROSTATE SPECIFIC MEMBRANE ANTIGEN//PSMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | STEAP4 | Author keyword | 14 | 100% | 6% | 7 |
2 | STAMP2 | Author keyword | 11 | 100% | 5% | 6 |
3 | STEAP | Author keyword | 9 | 83% | 4% | 5 |
4 | STEAP1 | Author keyword | 8 | 75% | 5% | 6 |
5 | PHYDE | Author keyword | 3 | 100% | 3% | 3 |
6 | DEV IMMUNOLJST C T | Address | 2 | 67% | 2% | 2 |
7 | PARM 1 | Author keyword | 2 | 67% | 2% | 2 |
8 | INFLAMMATION AMPLIFIER | Author keyword | 1 | 100% | 2% | 2 |
9 | TIARP | Author keyword | 1 | 100% | 2% | 2 |
10 | TNFAIP9 | Author keyword | 1 | 100% | 2% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | STEAP4 | 14 | 100% | 6% | 7 | Search STEAP4 | Search STEAP4 |
2 | STAMP2 | 11 | 100% | 5% | 6 | Search STAMP2 | Search STAMP2 |
3 | STEAP | 9 | 83% | 4% | 5 | Search STEAP | Search STEAP |
4 | STEAP1 | 8 | 75% | 5% | 6 | Search STEAP1 | Search STEAP1 |
5 | PHYDE | 3 | 100% | 3% | 3 | Search PHYDE | Search PHYDE |
6 | PARM 1 | 2 | 67% | 2% | 2 | Search PARM+1 | Search PARM+1 |
7 | INFLAMMATION AMPLIFIER | 1 | 100% | 2% | 2 | Search INFLAMMATION+AMPLIFIER | Search INFLAMMATION+AMPLIFIER |
8 | TIARP | 1 | 100% | 2% | 2 | Search TIARP | Search TIARP |
9 | TNFAIP9 | 1 | 100% | 2% | 2 | Search TNFAIP9 | Search TNFAIP9 |
10 | CANCER LIVER | 1 | 50% | 1% | 1 | Search CANCER+LIVER | Search CANCER+LIVER |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ADIPOSE RELATED PROTEIN | 42 | 94% | 13% | 15 |
2 | 6 TRANSMEMBRANE EPITHELIAL ANTIGEN | 11 | 47% | 14% | 17 |
3 | STAMP2 | 11 | 100% | 5% | 6 |
4 | 6 TRANSMEMBRANE PROTEIN | 11 | 78% | 6% | 7 |
5 | IL 6 AMPLIFIER | 6 | 80% | 3% | 4 |
6 | STEAP | 6 | 100% | 3% | 4 |
7 | STEAP4 | 3 | 100% | 3% | 3 |
8 | STEAP PROTEINS | 2 | 44% | 3% | 4 |
9 | PROSTATE 4 STEAP4 | 1 | 100% | 2% | 2 |
10 | GALECTIN 1 GENE | 1 | 50% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Inflammation Amplifier, a New Paradigm in Cancer Biology | 2014 | 21 | 27 | 19% |
Regulatory roles of tumor necrosis factor alpha-induced proteins (TNFAIPs) 3 and 9 in arthritis | 2014 | 2 | 24 | 54% |
STEAP Proteins: From Structure to Applications in Cancer Therapy | 2012 | 15 | 81 | 44% |
STAMPing into Mitochondria | 2014 | 1 | 40 | 63% |
The STEAP protein family: Versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions | 2012 | 8 | 110 | 45% |
The gateway theory: bridging neural and immune interactions in the CNS | 2013 | 3 | 19 | 37% |
STEAP4 and insulin resistance | 2014 | 0 | 86 | 45% |
The Gateway Reflex, which is mediated by the inflammation amplifier, directs pathogenic immune cells into the CNS | 2014 | 0 | 25 | 36% |
The Pathological and Physiological Roles of IL-6 Amplifier Activation | 2012 | 15 | 31 | 16% |
The Reverse-Direction Method Links Mass Experimental Data to Human Diseases | 2014 | 0 | 29 | 24% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DEV IMMUNOLJST C T | 2 | 67% | 1.7% | 2 |
2 | DEV IMMUNOL MED | 1 | 50% | 0.8% | 1 |
3 | INSERM 487 | 1 | 50% | 0.8% | 1 |
4 | NEURAL STEM CELL UNIT | 1 | 50% | 0.8% | 1 |
5 | PATHOL C2 | 1 | 50% | 0.8% | 1 |
6 | FRONTIER BIOSCI MED | 1 | 25% | 1.7% | 2 |
7 | JST C T FRONTIER BIOSCI | 0 | 33% | 0.8% | 1 |
8 | MED AH | 0 | 33% | 0.8% | 1 |
9 | NEUROL SURGNEUROSCI PROGRAM | 0 | 33% | 0.8% | 1 |
10 | QEHB S | 0 | 33% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000249098 | NORPEG//N COPINE//PSGR |
2 | 0.0000200450 | PROSTATE STEM CELL ANTIGEN//PROSTATE STEM CELL ANTIGEN PSCA//PSCA |
3 | 0.0000108474 | NYGGF4//LYRM1//ZBED6 |
4 | 0.0000085344 | TCTP//TRANSLATIONALLY CONTROLLED TUMOR PROTEIN//TRANSLATIONALLY CONTROLLED TUMOR PROTEIN TCTP |
5 | 0.0000068100 | A20//STRESS ASSOCIATED PROTEIN//ZINC FINGER PROTEIN A20 |
6 | 0.0000065436 | HEPCIDIN//FERROPORTIN//PROHEPCIDIN |
7 | 0.0000059206 | BCL2L12//BCL2 FAMILY//G P ANICOLAOU ONCOL |
8 | 0.0000059006 | ADIPOSE TISSUE MACROPHAGES//OBES BIOL UNIT//OBESITY INDUCED INFLAMMATION |
9 | 0.0000049484 | H 411E CELLS//JIANG TANG KE LI JTKL//ADIPOCYTE SECRETED FACTORS |
10 | 0.0000047513 | NKX31//LOBUND//3 2 DIMETHYL 4 AMINOBIPHENYL |